doi: 10.1016/s0022-3476(96)70339-6.
A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia
Affiliations
- PMID: 8648546
- DOI: 10.1016/s0022-3476(96)70339-6
Item in Clipboard
A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia
J Pediatr.
1996 Jun.
Abstract
Febrile neutropenic children with cancer were eligible for outpatient management with intravenous ceftriaxone therapy if they displayed selected low-risk criteria. Nineteen children were enrolled. All patients had sterile blood cultures, and only one of them was hospitalized because of persistent fever. This pilot study suggests that selected children with febrile neutropenia might be successfully managed without hospitalization.
Comment in
-
Outpatient treatment with ceftriaxone alone or in combination with teicoplanin in febrile neutropenic children and adolescents with cancer.J Pediatr. 1997 Mar;130(3):500-1. doi: 10.1016/s0022-3476(97)70224-5. J Pediatr. 1997. PMID: 9063436 No abstract available.
Similar articles
-
Outpatient treatment with ceftriaxone alone or in combination with teicoplanin in febrile neutropenic children and adolescents with cancer.J Pediatr. 1997 Mar;130(3):500-1. doi: 10.1016/s0022-3476(97)70224-5. J Pediatr. 1997. PMID: 9063436 No abstract available.
-
Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.Cancer. 2001 Apr 15;91(8):1563-7. doi: 10.1002/1097-0142(20010415)91:8<1563::aid-cncr1166>3.0.co;2-c. Cancer. 2001. PMID: 11301406 Clinical Trial.
-
[Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia].Wien Med Wochenschr. 1998;148(18):427-32. Wien Med Wochenschr. 1998. PMID: 9888179 Review. German.
-
Ceftriaxone in the outpatient treatment of cancer patients with fever and neutropenia.Eur J Clin Microbiol Infect Dis. 1998 Jul;17(7):501-4. doi: 10.1007/BF01691133. Eur J Clin Microbiol Infect Dis. 1998. PMID: 9764553 Clinical Trial.
-
[Antimicrobial therapy of febrile neutropenia--current developments].Wien Med Wochenschr. 2001;151(3-4):66-72. Wien Med Wochenschr. 2001. PMID: 11789421 Review. German.
Cited by
-
Repeating blood cultures in neutropenic children with persistent fevers when the initial blood culture is negative.Pediatr Blood Cancer. 2013 Jun;60(6):923-7. doi: 10.1002/pbc.24358. Epub 2012 Oct 9. Pediatr Blood Cancer. 2013. PMID: 23047811 Free PMC article.
-
Ambulatory use of parenteral antibacterials: contemporary perspectives.Drugs. 2000;59 Suppl 3:1-8; discussion 47-9. doi: 10.2165/00003495-200059003-00001. Drugs. 2000. PMID: 10845408 Review.
-
Pharmacological properties of parenteral cephalosporins: rationale for ambulatory use.Drugs. 2000;59 Suppl 3:9-18; discussion 47-9. doi: 10.2165/00003495-200059003-00002. Drugs. 2000. PMID: 10845409 Review.
-
[Bacteraemia risk criteria in the paediatric febrile neutropenic cancer patient].Clin Transl Oncol. 2005 May;7(4):165-8. doi: 10.1007/BF02708754. Clin Transl Oncol. 2005. PMID: 15960924 Spanish.
-
Antibiotic treatment of febrile episodes in neutropenic cancer patients. Clinical and economic considerations.Drugs. 1997 May;53(5):789-804. doi: 10.2165/00003495-199753050-00005. Drugs. 1997. PMID: 9129866 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
